Tag: Prednisone

Fully tapering glucocorticosteroids may be a viable option for GPA

Presented By
Prof. Peter Merkel, University of Pennsylvania, PA, USA
Trial
Phase 3, TAPIR
Conference
ACR 2024
Type
Peer-reviewed article

13 January 2025 11:23

Head-to-head: VMP versus Rd in transplant-ineligible MM

Presented By
Dr Sara Bringhen, Università degli Studi di Torino, Italy
Trial
Phase 4, REAL-MM
Conference
ASH 2022
Type
Peer-reviewed article

20 February 2023 11:47

Is avacopan better than prednisone for respiratory ANCA-associated vasculitis outcomes?

Presented By
Prof. Ulrich Specks, Mayo Clinic, MN, USA
Trial
Phase 3, ADVOCATE
Conference
ATS 2022
Type
Peer-reviewed article

18 July 2022 11:56

Significant tumour response to neoadjuvant therapy in high-risk non-metastatic prostate cancer

Presented By
Prof. Neil Fleshner, Princess Margaret Cancer Centre, Canada
Trial
Phase 2, ACDC-RP
Conference
ASCO GU 2022
Type
Peer-reviewed article

8 April 2022 11:22

Addition of abiraterone to ADT/docetaxel does not increase bone loss

Presented By
Dr Guilhem Roubaud, Institut Bergonié, France
Trial
Phase 3, PEACE-1
Conference
ASCO GU 2022
Type
Peer-reviewed article

8 April 2022 11:21

POLARIX: Novel regimen superior to R-CHOP in DLBCL

Presented By
Prof. Hervé Tilly, University of Rouen, France
Trial
Phase 3, POLARIX
Conference
ASH 2021
Type
Peer-reviewed article

4 February 2022 10:56

ASH 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ASH 2021

4 January 2022 08:00

Both men with high-risk non-metastatic prostate cancer and men with metastatic prostate cancer benefit from intensified hormone treatment

Trial
Phase 3, PEACE-1, STAMPEDE, ARCHES
Conference
ESMO 2021
Type
Peer-reviewed article

19 November 2021 09:27

Apalutamide prolongs progression-free survival in prostate cancer

Presented By
Dr Dana Rathkopf, Memorial Sloan Kettering Cancer Center, New York, USA
Trial
Phase 3, ACIS
Conference
ASCO GU 2021
Type
Peer-reviewed article

24 March 2021 14:49

ALCYONE: New overall survival results for myeloma

Presented By
Dr Maria Victoria Mateos, University Hospital of Salamanca, Spain
Trial
Phase 3, ALCYONE
Conference
ASH 2019
Type
Peer-reviewed article

5 March 2020 16:16

Prolonged remission after stop of tocilizumab for patients with giant cell arteritis

Presented By
Prof. John H. Stone, Harvard Medical School, Boston, USA
Trial
Phase 3, GiACTA
Conference
ACR 2019
Type
Peer-reviewed article

4 February 2020 10:19

Tapering of prednisone in RA patients who achieved low disease activity or remission with tocilizumab

Presented By
Prof. Gerd Burmester, Free University and Humboldt University of Berlin, Germany
Conference
EULAR 2019
Type
Peer-reviewed article

4 September 2019 16:56

Bruton’s tyrosine kinase inhibitor highly effective in pemphigus vulgaris

Presented By
Prof. Dedee Murrell, University of New South Wales, Australia
Conference
AAD 2019
Type
Peer-reviewed article

19 April 2019 15:36
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com